Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Fu, Dehao ^a   He, Xianfeng ^b   Yang, Shuhua ^a   Xu, Weihua ^a   Lin, Tao ^a   Feng, Xiaobo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NINGBO NO 6 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; F ACTIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ZOLEDRONIC ACID; ANGIOGENESIS INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL SURFACE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOSKELETON; CYTOSOL; DRUG EFFECT; GENE TRANSLOCATION; IMMUNOBLOTTING; IN VITRO STUDY; LASER CONFOCAL MICROSCOPY; LASER MICROSCOPY; LM8 OSTEOSARCOMA CELL; MICROVILLUS; MOUSE; NONHUMAN; OSTEOSARCOMA CELL; SCANNING ELECTRON MICROSCOPY; VASCULOGENIC MIMICRY; ANIMAL; BONE TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); ORGAN CULTURE TECHNIQUE; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE; ULTRASTRUCTURE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; CELL LINE, TUMOR; DIPHOSPHONATES; IMIDAZOLES; MICE; MICROVILLI; NEOVASCULARIZATION, PATHOLOGIC; ORGAN CULTURE TECHNIQUES; OSTEOSARCOMA; PROTEIN TRANSPORT; RHOA GTP-BINDING PROTEIN;

EID: 79959683418     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-146     Document Type: Article

References (15)

1. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. AJ Maniotis R Folberg A Hess EA Seftor LM Gardner J Pe'er JM Trent PS Meltzer MJ Hendrix, Am J Pathol 1999 155 739 752 10.1016/S0002-9440(10)65173-5 10487832 (Pubitemid 29426820)
2. Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. SA Ahmadi M Moinfar K Gohari Moghaddam M Bahadori, Arch Iran Med 2010 13 498 503 21039005
3. Investigation of vasculogenic mimicry in sebaceous carcinoma of the eyelid. X Xu R Jia Y Zhou X Song X Fan, Acta Ophthalmo 2010 88 160 164 10.1111/j.1755-3768.2010.01942.x
4. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. S El Hallani B Boisselier F Peglion A Rousseau C Colin A Idbaih Y Marie K Mokhtari JL Thomas A Eichmann JY Delattre AJ Maniotis M Sanson, Brain 2010 133 973 982 10.1093/brain/awq044 20375132
5. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. M Clemente MD Pérez-Alenza JC Illera L Pẽa, Vet Patho 2010 47 265 274 10.1177/0300985809353167
6. Zoledronic acid: a review of its use in the management of bone metastases of malignancy. S Dhillon KA Lyseng-Williamson, Drugs 2008 68 507 534 10.2165/00003495-200868040-00010 18318568 (Pubitemid 351342020)
7. Zoledronic acid. R Burkinshaw M Winter H Neville-Webbe J Lester E Woodward J Brown, Expert Opin Drug Saf 2011 10 133 145 10.1517/14740338.2011. 540387 21114419
8. Anticancer properties of zoledronic acid. J Green A Lipton, Cancer Invest 2010 28 944 957 10.3109/07357907.2010.512598 20879838
9. Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model. PD Ottewell DV Lefley SS Cross CA Evans RE Coleman I Holen, Int J Cancer 2010 126 522 532 10.1002/ijc.24756 19621384
10. Effect of zoledronic acid on proliferation, apoptosis and expression of VEGF of osteosarcoma cell line LM8. HE Xian-feng YANG Shu-hua FU De-hao LIU Jia-guo HU Yong HE Yu WANG Qing-de, China Oncology 2007 17 531 535
11. Zoledronic acid - a multiplicity of anti-cancer action. T Yuasa S Kimura E Ashihara T Habuchi T Maekawa, Curr Med Chem 2007 14 2126 2135 17691952 (Pubitemid 47578153)
12. Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition. M Chaplet C Detry C Deroanne LW Fisher V Castronovo A Bellahcéne, Biochem J 2004 384 591 598 10.1042/BJ20040380 15324309 (Pubitemid 40018973)
13. New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects. C Denoyelle L Hong JP Vannier J Soria C Soria, Br J Cancer 2003 88 1631 1640 10.1038/sj.bjc.6600925 12771933 (Pubitemid 36713793)
14. Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells. M Koizumi C Nakaseko C Ohwada M Takeuchi S Ozawa N Shimizu R Cho M Nishimura Y Saito, Eur J Haematol 2007 79 382 391 10.1111/j.1600-0609.2007.00957.x 17903213 (Pubitemid 47556496)
15. Signalling pathways in vasculogenic mimicry. YW Paulis PM Soetekouw HM Verheul VC Tjan-Heijnen AW Griffioen, Biochim Biophys Acta 2010 1806 18 28 20079807